These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. [Treatment of Crohn's disease with anti-TNF alpha antibodies (infliximab): results of a multicentric and retrospective study]. Doubremelle M; Bourreille A; Zerbib F; Heresbach D; Metman EH; Beau P; Gournay J; Galmiche JP Gastroenterol Clin Biol; 2002 Nov; 26(11):973-9. PubMed ID: 12483127 [TBL] [Abstract][Full Text] [Related]
31. Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated? Domènech E; Hinojosa J; Nos P; Garcia-Planella E; Cabré E; Bernal I; Gassull MA Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1107-13. PubMed ID: 16305724 [TBL] [Abstract][Full Text] [Related]
32. Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study. Orlando A; Colombo E; Kohn A; Biancone L; Rizzello F; Viscido A; Sostegni R; Benazzato L; Castiglione F; Papi C; Meucci G; Riegler G; Mocciaro F; Cassinotti A; Cosintino R; Geremia A; Morselli C; Angelucci E; Lavagna A; Rispo A; Bossa F; Scimeca D; Cottone M; Dig Liver Dis; 2005 Aug; 37(8):577-83. PubMed ID: 15886081 [TBL] [Abstract][Full Text] [Related]
33. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease. Hukkinen M; Pakarinen MP; Piekkala M; Koivusalo A; Rintala R; Kolho KL J Crohns Colitis; 2014 Aug; 8(8):756-62. PubMed ID: 24447625 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn's disease--clinical observations from a tertiary Eastern European center. Bor R; Farkas K; Bálint A; Szucs M; Ábrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T Scand J Gastroenterol; 2015 Feb; 50(2):182-7. PubMed ID: 25384713 [TBL] [Abstract][Full Text] [Related]
35. Biological immunomodulators improve the healing rate in surgically treated perianal Crohn's fistulas. El-Gazzaz G; Hull T; Church JM Colorectal Dis; 2012 Oct; 14(10):1217-23. PubMed ID: 22251452 [TBL] [Abstract][Full Text] [Related]
37. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians. Sandborn WJ; Hanauer SB Am J Gastroenterol; 2002 Dec; 97(12):2962-72. PubMed ID: 12492177 [TBL] [Abstract][Full Text] [Related]
38. Perianal inflammatory conditions in inflammatory bowel disease. Stein BL; Gordon PH Curr Opin Gen Surg; 1993; ():141-6. PubMed ID: 7583950 [TBL] [Abstract][Full Text] [Related]
40. [Perianal infections in Crohn disease. Results of local surgical treatment in comparison with non-Crohn patients]. Hancke E Med Klin (Munich); 1992 Jun; 87(6):305-9. PubMed ID: 1635520 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]